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Abstract
Background: Apart from the platelet/endothelial cell adhesion molecule 1 (PECAM-1, CD31), endoglin (CD105) and a
positive factor VIII-related antigen staining, human primary and immortalized macro- and microvascular endothelial cells
(ECs) differ in their cell surface expression of activating and inhibitory ligands for natural killer (NK) cells. Here we
comparatively study the effects of irradiation on the phenotype of ECs and their interaction with resting and activated NK
cells.
Methodology/Principal Findings: Primary macrovascular human umbilical vein endothelial cells (HUVECs) only express
UL16 binding protein 2 (ULBP2) and the major histocompatibility complex (MHC) class I chain-related protein MIC-A (MIC-A)
as activating signals for NK cells, whereas the corresponding immortalized EA.hy926 EC cell line additionally present ULBP3,
membrane heat shock protein 70 (Hsp70), intercellular adhesion molecule ICAM-1 (CD54) and HLA-E. Apart from MIC-B, the
immortalized human microvascular endothelial cell line HMEC, resembles the phenotype of EA.hy926. Surprisingly, primary
HUVECs are more sensitive to Hsp70 peptide (TKD) plus IL-2 (TKD/IL-2)-activated NK cells than their immortalized EC
counterpatrs. This finding is most likely due to the absence of the inhibitory ligand HLA-E, since the activating ligands are
shared among the ECs. The co-culture of HUVECs with activated NK cells induces ICAM-1 (CD54) and HLA-E expression on
the former which drops to the initial low levels (below 5%) when NK cells are removed. Sublethal irradiation of HUVECs
induces similar but less pronounced effects on HUVECs. Along with these findings, irradiation also induces HLA-E expression
on macrovascular ECs and this correlates with an increased resistance to killing by activated NK cells. Irradiation had no
effect on HLA-E expression on microvascular ECs and the sensitivity of these cells to NK cells remained unaffected.
Conclusion/Significance: These data emphasize that an irradiation-induced, transient up-regulation of HLA-E on
macrovascular ECs might confer protection against NK cell-mediated vascular injury.
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Introduction
The endothelial cell (EC) monolayer which lines blood vessels
performs multiple tasks including the regulation of tissue fluid
homeostasis and blood cell transmigration. The interaction of ECs
with leukocytes, such as activated NK cells, involves attachment
and rolling which are predominantly mediated by selectins and
carbohydrate-rich ligands, such as mucins [1–3]. Lymphocyte
rolling might induce activation and facilitate the tight adhesion to
ECs which is enabled by the integrin family of cell adhesion
molecules [4]. The ligation, migration and extravasation of
lymphocytes into the tissue has been postulated to be mediated
by PECAM-1 (CD31) and involves the activation of integrins such
as a4/b1 (VLA-4) [4,5], a4/b7 [5,6], a4/b2 (LFA-1, CD11a/
CD18) [5–7], and aM/b2 (CR3, Mac-1, CD11b/CD18a) [7].
NK cells play pivotal roles in the early defence against viral
infections and malignant transformations [8–10]. The functional-
ity of NK cells is regulated by interactions of inhibitory and
activating receptors [11,12] which belong either to the immuno-
globulin (Ig)-like (KIR), Ig-like transcript (ILT), C-type lectin or
natural cytotoxicity group, with the signals being derived from the
target cell ligands [13]. Inhibitory receptors with specificity for
classical and non-classical MHC class I molecules mediate
protection for the target cells. HLA-E, a prominent member of
the non-classical MHC (MHC class Ib), which is recognized by
CD94/NKG2A (inhibitory) and CD94/NKG2C (activating)
expressing NK cells, is characterized by a limited polymorphism
and a tissue-specific and inducible expression pattern [14,15].
According to the ‘‘missing-self’’ theory [16], the partial or
complete loss of MHC antigens can also render target cells
susceptible to NK cells. The mechanism of killing by NK cells
involves exocytosis of cytolytic granules containing apoptotic
enzymes, such as granzymes and perforins and death receptor
ligands such as Fas/Fas-ligand [17–24]. Our group has identified a
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recognition structure for a perforin-independent, granzyme B-
mediated attack by allogeneic and autologous NK cells that have
been pre-stimulated with Hsp70 peptide TKD plus low dose IL-2
[26,27].
Activated NK cells have been found to bind to the
microvasculature of metastases [28] and to play a crucial role in
the control of tumor angiogenesis [29,30]. In this context, we were
interested to study the interactions of TKD/IL-2- stimulated NK
cells with macro- and microvascular primary and immortalized
ECs. An NK cell based phase I clinical study [31] which used ex
vivo TKD/IL-2-activated NK cells to treat patients with colorectal
and non-small cell lung (NSCLC) carcinoma has shown promising
results with respect to the feasibility and safety of the procedure
and its ability to enhance the capacity of patient-derived NK cells
to kill membrane Hsp70
+ tumor cells in vitro. The goal of a
subsequent proof-of-concept phase II clinical trial is to analyze the
efficacy of TKD/IL-2-activated NK cells in NSCLC patients
following radiochemotherapy as this has been shown to enhance
the density of Hsp70 membrane expression on tumor cells
(unpublished observations). Therefore, we were interested to study
the surface expression of activating and inhibitory ligands on
primary and immortalized macro- and microvascular ECs before
and after irradiation.
Immortalized EC lines present Hsp70 on their plasma
membrane and thus reflect a tumorigenic phenotype. The
expression of ligands such as ULBP1-3 [32], MIC-A/-B, Hsp70,
and HLA-E and the membrane-bound [33] form of the
intercellular adhesion molecule ICAM-1 (CD54) was then
correlated with the NK cell mediated cytotoxicity. Our findings
suggest that HLA-E is a key player in the regulation of NK cell
mediated killing of ECs. A movie showing the interaction of
TKD/IL-2-activated NK cells and ECs indicates that a bulk of
NK cells actively migrates towards ECs. Next, we studied the
effects of ionizing irradiation on the expression of cell surface
markers which might affect the killing activity of NK cells. We
could demonstrate that an irradiation at 4 Gy results in a
significantly up-regulated expression density of HLA-E on primary
(HUVEC) and immortalized macrosvascular (EA.hy926) ECs, but
not on immortalized microvascular HMEC. Despite a minor
irradiation-induced increase in activating ligands, the significant
increase in the HLA-E expression on macrovascular ECs led to a
reduced lysis of HUVECs and EA.hy926 cells. The HLA-E
expression density on the immortalized microvascular cell line
HMEC did not change significantly by irradiation and thus the
lysis remained unaltered.
Results
Comparative Analysis of the Phenotype of Human
Primary and Immortalized Macro- and Microvascular ECs
The phenotype of the primary (HUVEC; Figure 1A) [34] and
immortalized macro- (EA.hy926; Figure 1B) and immortalized
microvascular (HMEC; Figure 1C) endothelial cells was deter-
mined by immunofluorescence microscopy and flow cytometry.
All three endothelial cell types show a positive staining for the
factor VIII-related antigen (Figure 1A–C) and strongly express the
endothelial cell associated markers CD31 (platelet/endothelial cell
adhesion molecule 1, PECAM-1), [35] and CD105 (endoglin)
[36], a component of the TGF-beta 1 receptor complex, which is
also involved in vascular remodelling (Table 1). Under shear stress
induced by a flow system (IBIDI, Martinsried, Germany) for 12 h
(Figure 1D; lower panel), but not under static culture conditions
(Figure 1D; upper panel), HUVECs (Figure 1D, left), EA.hy926
cells (Figure 1D, middle) cells and to a lesser extent also HMECs
(Figure 1D, right) exhibit the typical cobblestone morphology and
a reorientation in line with the dynamic flow.
In contrast to the immortalized ECs, the primary macrovascular
human umbilical vein endothelial cells (HUVECs) only present
UL16 binding protein 2 (ULBP2), the major histocompatibility
complex (MHC) class I chain-related protein MIC-A and classical
MHC class I antigens (HLA-A, -B, -C) on their cell surface. A
comparative analysis of the expression pattern of MIC-A, ICAM-1
(CD54) and HLA-E expression on ECs under static and flow
conditions revealed no significant differences (data not shown).
In comparison to HUVECs, the immortalized EA.hy926 cell
line expresses additional markers such as ULBP3, ICAM-1 (CD54)
and the human leukocyte antigen E (HLA-E) on their cell
membrane. The human microvascular endothelial cell line
HMEC was immortalized by a transfection of primary dermal
ECs with a PBR322 plasmid containing the coding region for the
simian virus 40A gene product, large T antigen. This cell line
resembles the phenotype of EA.hy926 cells with the exception that
the MIC-A expression is substituted by MIC-B in HMECs.
Although a translocation of the major stress-inducible heat shock
protein 70 (Hsp70) to the plasma membrane [36,37] is typically
associated with a tumorigenic phenotype, since normal cells are
membrane Hsp70
2, a membrane Hsp70
+ phenotype was
selectively detectable on immortalized EA.hy926 cells and
HMECs using the cmHsp70.1 mAb (multimmune GmbH,
Munich, Germany), but not on primary HUVECs. In contrast
to the cmHsp70.1 mAb, other commercially available Hsp70-
specific antibodies, such as SPA810, do not react with the
membrane form of Hsp70 on tumor cells (manuscript submitted)
or that on immortalized ECs.
Interaction of EC with Un-Stimulated and Stimulated NK
Cells
The enrichment of NK cells was based on a negative selection
procedure of peripheral blood mononuclear cells (PBMNCs) using
Miltenyi microbeads coupled to anti-CD3 (T cell depletion) and
anti-CD19 (B cell depletion) mAbs. Following the negative
selection, an adherence step was included to reduce the number
of CD14
+ monocytes and macrophages. The final population
typically contained between 50 and 60% of CD3
2 NK cells, which
were found to be positive for the neuronal cell adhesion molecule
CD56 [38], the low affinity Fc-gamma receptor CD16 and the C-
type lectin receptor CD94 (Figure 2). Enriched NK cells were
either un-stimulated (Figure 2, grey bars) or were stimulated with
Hsp70 peptide TKD plus low dose IL-2 (TKD/IL-2) for 4 days
(Figure 2, black bars). Although no significant changes were
observed with respect to the percentage of CD16, CD56 and
CD94 positive cells, the stimulation with TKD/IL-2 resulted in a
significant up-regulation in the expression density (mfi) of these
antigens (Figure 2).
Differences in the adhesion of un-stimulated and TKD/IL-2-
activated NK cells to HMECs under static conditions using
microscopic and immunofluorescence analysis of PKH26GL-
labeled NK cells (red fluorescence) and FITC-labeled (green
fluorescence) HMECs are illustrated in Figure 3. Following a 4 h
co-incubation, the number of ECs in culture wells containing
activated NK cells (Figure 3B) was significantly reduced from
7365t o3 7 63 ECs per optical field (p,0.05; n=3), compared to
culture wells containing resting NK cells (Figure 3A). Furthermore,
the adhesion of activated NK cells to ECs was dramatically greater
than that to resting NK cells. The close interaction of activated
NK cells with ECs was confirmed using fluorescence microscopy.
The adherence of activated PKH26GL-labeled NK cells (red) to
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spectrum (Figure 3D). In contrast, no co-localization was
detectable if HMECs were co-cultured for 4 h with resting NK
cells (Figure 3C). Movies illustrating the differences in the kinetics
of the adherence and the concerted attack of HMECs by TKD/
IL-2-stimulated NK cells in comparison to resting NK cells are
included in the supplementary information. It appears that
activated (video S2 and video S3), but not resting NK cells (video
S1), actively migrate towards HMECs and that this interaction
results in the detachment and elimination of HMECs.
HLA-E Expression Partially Protects EA.hy926 Cells and
HMECs from Lysis by Activated NK Cells
We have previously shown that TKD/IL-2-activated NK cells
kill their tumor target cells via a perforin-independent, granzyme
B mediated lysis [27]. HUVECs, EA.hy926 cells and HMECs
were sensitive to granzyme B mediated apoptosis by TKD/IL-2-
activated NK cells (Figure 4A), whereas none of the three ECs
were lysed to a significant extent by resting NK cells (data not
shown). However, the lysis of primary macrovascular HUVECs by
activated NK cells was always considerably greater than that of its
corresponding immortalized cell line EA.hy926 and the immor-
talized microvascular cell line HMEC (Figure 4A/B). This finding
was not expected, since the immortalized ECs express ULBP3 and
membrane Hsp70, in addition to ULBP1 and MIC-A/-B as
activating ligands for TKD/IL-2-stimulated NK cells. We
therefore assumed that the increased susceptibility of HUVECs
to activated NK cells was most likely due to the absence of the
inhibitory ligand HLA-E. A comparison of the lysis of HUVECs
and HMECs in a standard
51Cr release assay confirmed the data
that were obtained using the granzyme B ELISPOT assay
(Figure 4B).
Phenotypic Changes of Cell Surface Markers on ECs after
Contact with Activated NK Cells
The proportion of marker positive target cells and the cell
surface density of the markers following co-incubation of the ECs
with resting and activated NK cells for 12 h were analyzed by flow
cytometry in the separately gated cell populations. Apart from
MIC-A, ICAM-1 (CD54) and HLA-E, none of the cell surface
markers appeared to be affected by the contact with NK cells. The
cell surface density of CD31 and CD105, as typical EC-related
markers, also remained unchanged (data not shown). As
summarized in Figure 5A (left panel), the percentage of MIC-A
+
Figure 1. Von Willebrand staining and microscopic analysis of endothelial cells (ECs). Representative immunofluorescence images of
primary macrovascular HUVECs (A), immortalized macrovascular EA.hy926 cells (B) and immortalized microvascular HMECs (C) stained for von
Willebrand factor (FITC, green spectrum); nucleus is counter-stained with DAPI (blue spectrum); scale bar, 100 mm. (D) Microscopic analysis of HUVECs
(left panel), EA.hy926 cells (middle panel) and HMECs (right panel) under static (upper panel) and under flow conditions for 12 h (lower panel), scale
bar, 200 mm. Under flow the ECs show the typical cobblestone morphology.
doi:10.1371/journal.pone.0015339.g001
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A
+ in its corresponding immortalized partner cell line EA.hy926.
The cell surface density of MIC-A on the surviving cell fraction
remained unaltered in HUVECs and EA.hy926 cells (Figure 5A,
right panel). The microvascular cell line HMEC, which contains a
very low proportion of MIC-A
+ cells showed a decrease in the
surface density of this marker (Figure 5A, right panel), and there
was also a small reduction in the proportion of MIC-B
+ cells (data
not shown). With respect to the intercellular adhesion molecule
ICAM-1 (CD54), all three EC types reacted similarly by
significantly up-regulating the percentage of cells expressing this
adhesion molecule and its cell surface density following contact
with activated NK cells (Figure 5B). The most striking difference
between the EC types was observed with respect to the expression
of HLA-E. After contact with activated NK cells, but not with
resting NK cells, the percentage of HLA-E
+ HUVECs increased
from below 5% up to nearly 100% within 12 h (Figure 5C). Since
the doubling time of HUVECs is slow (24 h), these results suggest
that HLA-E is actively up-regulated in primary macrovascular
ECs. In contrast, almost all EA.hy926 cells and HMECs initially
showed a membrane HLA-E
+ phenotype and contact with
activated NK cells only enhanced the density of HLA-E expression
(Figure 5C). In contrast to TKD/IL-2-activated NK cells, resting
NK cells had no influence on the viability of the ECs, nor did they
alter the expression of MIC-A, ICAM-1 (CD54) and HLA-E.
The dramatic up-regulation of ICAM-1 (CD54) and HLA-E on
HUVECs was transient, since the levels of these proteins on the
cell surface dropped to the very low baseline levels following the
removal of activated NK cells (Figure 5D). Similar effects were
seen with the increased density of these antigens on the
immortalized EC types (data not shown).
An Irradiation-Induced Up-Regulation of HLA-E
Decreases Sensitivity to Activated, NKG2A and NKG2C
Expressing NK Cells
Exposure to ionizing irradiation (4 Gy) followed by a recovery
period of 12 h significantly increased the expression density of
HLA-E on primary macrovascular HUVECs (Figure 6A) and also
the percentage of HLA-E positive cells (from below 5 up to 27%).
Similar effects were observed for the immortalized macrovascular
partner cell line EA.hy926 (Figure 6B). Although these effects were
similar to those induced by the contact of HUVECs with activated
NK cells, they were less pronounced. In contrast, ionizing
irradiation had no effect on the expression density of HLA-E on
immortalized microvascular HMECs (Figure 6C). None of the
other cell surface markers, such as MHC class I, ULBP1-3, MIC-
Table 1. Comparative analysis of the expression of activating
and inhibitory cell surface markers on primary and
immortalized ECs.
Primary
macrovascular Immortalized
Immortalized
microvascular
Expression
Pattern
ECs HUVEC EA.hy926 HMEC
HUVEC/
EA.hy926/
HMEC
Marker % (mean fluorescence intensity)
++ .70%
+ .20%
2 .10%
CD31 8964 (89) 9667 (96) 976 (92) ++/++/++
CD105 9766 (97) 9960.1 (99) 9962( 9 8 ) ++/++/++
ULBP1 061 (66) 060 (46) 461 (43) 2/2/2
ULBP2 4867 (59) 9662 (63) 9861( 1 3 1 ) +/++/++
ULBP3 663 (52) 58611 (52) 51611 (62) 2/+/+
MIC-A 7366 (107) 2164 (46) 863 (116) ++/+/2
MIC-B 361 (47) 261 (25) 36610 (37) 2/2/+
HLA-E 160 (11) 8663 (162) 8364( 2 0 1 ) 2/++/++
W6/32 9762 (48) 9869 (75) 9567( 6 7 ) ++/++/++
cmHsp70.1 664 (12) 5865 (69) 4866( 5 4 ) 2/+/+
SPA810 26 (51) 16 (91) 26 (44) 2/2/2
CD54 562 (88) 1362 (46) 2163( 4 9 ) 2/+/+
doi:10.1371/journal.pone.0015339.t001
Figure 2. Phenotyping of effector cells. Comparative analysis of T (CD3) and NK (CD16/56, CD94) cell specific markers on NK cell enriched
PBMNC preparations with and without stimulation with TKD (2 mg/ml) plus low dose IL-2 (100 IU/ml) for 4 days. Left panel, proportion of marker
positively stained cells in %; right panel, mean fluorescence intensity (mfi) values. Mean fluorescence values differing significantly between un-
stimulated and stimulated NK cells are marked with *, p,0.05.
doi:10.1371/journal.pone.0015339.g002
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following irradiation. In line with the increased cell surface
expression of HLA-E, the lysis of irradiated HUVECs (Figure 7A)
and EA.hy926 cells (Figure 7B) by activated NK cells expressing
NKG2A and NKG2C receptors decreased significantly, whereas
that of HMECs with an unaltered HLA-E membrane expression
remained unaffected (Figure 7C). Un-stimulated NK cells did not
affect the lysis of any of the EC types (Figure 7A–C) and also did
not change the cell surface marker expression pattern as shown in
Figure 5A–C.
Pre-incubation of TKD/IL-2-activated NK cells with NKG2A
and NKG2C antibodies and irradiated HUVECs (4Gy) with
HLA-E antibodies, demonstrated that the lysis of irradiated
HUVECs was significantly enhanced if NK cells had been pre-
incubated with the agonistic NKG2C mAb (Figure 8). Further-
more, the blocking of the inhibitory ligand HLA-E on irradiated
Figure 4. Granzyme B and
51Cr release assay of ECs by resting and activated NK cells. Granzyme B ELISPOT assay (4 h) of resting and TKD/
IL-2-activated NK cells attacking HUVECs, EA.hy926 cells and HMECs (A). The effector to target (E:T) ratios ranged between 10:1 to 0.16:1. The data
represent mean values of at least 3 independent experiments. The differences in lysis of HUVECs compared to that of EA.hy926 cells and HMECs was
significantly different *, p,0.05 at all E:T ratios. Standard
51Cr release assay (4 h) comparing the lysis of HUVECs and HMECs by resting and TKD/IL-2-
activated NK cells at effector to target ratios ranging from 10:1 to 0.31:1 (B). The data are from one typical experiment, therefore no statistical analysis
has been performed.
doi:10.1371/journal.pone.0015339.g004
Figure 3. Representative microscopic images of the adherence of TKD/IL-2-activated NK cells to HMECs. A confluent monolayer of
HMECs was co-cultured for 4 h either with resting (A) and TKD/IL-2-activated NK cells (B). Pictures were taken using a Zeiss Axiovert 200 inverted
fluorescence microscope. The amount of adherent HMECs was drastically reduced after a co-incubation with activated (B) compared to resting NK
cells (A). The number of HMECs co-cultured for 4 h with activated NK cells significantly dropped from 7365t o3 7 63 cells, as determined by counting
of an optical field (n=3, p,0.05). Scale bar, 50 mm. Representative immunofluorescence images of TKD/IL-2-activated NK cells to HMECs. The specific
adhesion of activated NK cells, labeled with PKH26GL in red, to HMECs, labeled with FITC in green, is illustrated in orange (D). No co-staining of red
and green labels was seen when resting NK cells were used (C). Pictures were taken using a Zeiss Axiovert 200 inverted fluorescence microscope.
doi:10.1371/journal.pone.0015339.g003
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EA.hy926 cells and HMECs expressing MIC-A (A), CD54 (B) and HLA-E (C) (left panel) and mean fluorescence intensity values of expression (mfi; right
panel) in the absence of NK cells (light grey bars) and after a 12 h co-culture with resting (dark grey bars) or TKD/IL-2-activated (black bars) NK cells.
Cell surface marker expression was determined by flow cytometry; ECs and NK cell populations were gated separately based on differences in the
forward (FSC) and side scatters (SSC). Asterisks mark values significantly different to control values, ***, p,0.001, as determined by the Mann-Whitney
test using the SPSS software. The expression of the cell surface markers indicated above on HUVECs in the presence of TKD/IL-2-activated NK cells
(black bars) and after removal of the NK cells (white bars) was determined by flow cytometry. In the absence of NK cells the elevated levels in the
expression of CD54 and HLA-E positively stained HUVECs dropped to initially low levels (D). Asterisks mark values which are significantly different to
control values, ***, p,0.001, as determined by the Mann-Whitney test using the SPSS software.
doi:10.1371/journal.pone.0015339.g005
Figure 6. Phenotyping of ECs before and after irradiation at 4 Gy. Comparative analysis of the mean fluorescence intensity values for ULBP1-
3, MIC-A/-B, CD54 (ICAM-1) and HLA-E expression on HUVECs (A), EA.hy926 cells (B) and HMECs (C) after ionizing irradiation at the sub-lethal dose of 4
Gy followed by a recovery period of 12 h. The MHC class I expression, as determined by W6/32 mAb, was measured only on HUVECs. The expression
density of HLA-E was found to be significantly reduced on HUVECs and EA.hy926 cells (*, p,0.05), but not on HMECs following irradiation. No
significant changes were observed with respect to other cell surface markers such as ULBP1-3, MIC-A/-B, CD54 and MHC class I antigens.
doi:10.1371/journal.pone.0015339.g006
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significantly enhanced lysis (Figure 8). In contrast, the lysis of
irradiated HUVECs was not significantly affected by pre-
incubating activated NK cells with the NKG2A mAb.
Discussion
Herein, we have studied the expression of activating and
inhibitory NK target ligands on human primary and immortalized
ECs before and after irradiation and monitored its immunomod-
ulatoryfunctions.AlthoughMHCclassI,MHCclassIrelated chain
MIC-A and MIC-B and ULBP1-3 are frequently up-regulated on
tumor cells by environmental stress [39], our findings indicate that a
sub-lethal irradiation dose of 4 Gy does not significantly increase
their cell surface expression on ECs. The MIC gene products [40]
and ULBP1-3 proteins act as activating ligands for the C-type lectin
receptor NKG2D [41–45] which is expressed on NK cells and via
which activated NK cells can specifically kill their tumor target cells.
We have previously shown that in contrast to normal tissues, tumors
frequently present the major stress-inducible heat shock protein 70
(Hsp70) on their plasma membrane [37,46]. Similar to MIC-A/-B
and ULBP1-3membrane Hsp70 also serves as recognition structure
for NK cells that have been activated by the Hsp70 peptide TKD
plus IL-2 (TKD/IL-2) [47], both on tumor cells in vitro and in tumor
mouse models [48,49]. Followingactivation, these NK cells showan
elevated expression density of a panel of different receptors
including the C-type lectin receptors CD94/NKG2A, CD94/
NKG2C, NKG2D and natural cytotoxicity receptors (NCRs)
Figure 7. Comparative analysis of the lysis of non-irradiaited and irradiated ECs. Comparative analysis of the lysis of non-irradiated and
irradiated (4 Gy) HUVECs (A), EA.hy926 cells (B) and HMECs (C) by un-stimulated and TKD/IL-2-stimulated NK cells. The data represent the mean values
of three independent experiments and were obtained using 4 h granzyme B ELISPOT assays. The effector to target ratios ranged from 10:1 to 0.16:1.
An asterisk marks values which are significantly different to values derived with non-irradiated target cells *, p,0.05 at all E:T ratios.
doi:10.1371/journal.pone.0015339.g007
Figure 8. Blocking of lysis of irradiated ECs by antibodies directed against NK effector and target cells. Activation/inhibition of the
granzyme B ELISPOT assay by antibodies directed against NKG2A, NKG2C or HLA-E. Comparative analysis of the lysis of irradiated (4 Gy) HUVECs
either untreated or pre-incubated with HLA-E antibody by TKD/IL-2-stimulated NK cells that were pre-incubated either with NKG2A or NKG2C
antibodies for 30 min. 5063.5% expressed NKG2A and 68615% of activated NK cells expressed NKG2C; 8162.8% of irradiated HUVECs expressed
HLA-E after contact with activated NK cells. The data represent the mean values of three experiments and were obtained using 4 h granzyme B
ELISPOT assays. The effector to target (E:T) ratio was 1:1. An asterisk marks values which are significantly different to values derived with non-
irradiated target cells *, p,0.05.
doi:10.1371/journal.pone.0015339.g008
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can be selectively enhanced by ionizing irradiation. Here, we were
interested to study the role of membrane Hsp70 as a recognition
structure for NK cells on non-irradiated and irradiated ECs. As
expected, only immortalized ECs exhibited a membrane Hsp70
+
phenotype. We assume that the fusion of primary HUVECs with
the membrane Hsp70
+ tumor cell line A549-8, as well as the
transformation of primary dermal microvascular ECs with the
SV40 large T antigen, result in a malignant transformation of ECs
which enables the translocation of Hsp70 to the plasma membrane
in a manner which is analogous to that apparent for tumor cells. We
therefore speculate that immortalized ECs might in part reflect the
phenotype of a tumor cell. However, in contrast to tumor cells,
neither primary and nor immortalized ECs exhibited significant up-
regulation of membrane Hsp70 density after ionizing irradiation
(data not shown).
Although HLA-E transcripts are always present in ECs [14], the
HLA-E surface expression is highly variable. HLA-E is known to
act as a negative regulatory signal for NK cells expressing the
inhibitory receptor CD94/NKG2A and thus might confer
immune regulatory functions [50,51]. Trophoblasts and tumor
cells protect themselves against the attack by the innate immune
system via the expression of HLA-E [52,53]. We have previously
shown that transfection of HLA-E down-regulates the cytolytic
response of TKD/IL-2-activated NK cells against tumor cells [54].
Along with these findings, HLA-E also plays a protective role
against NK cells in the field of xenotransplantation. HLA-E
transgenic pigs expressing human HLA-E on PBMNC and ECs
were found to be protected against NK cell mediated killing [55].
When comparing the HLA-E phenotype in macro- and micro-
vascular ECs with their susceptibility for NK cell mediated
cytolysis, the absence of HLA-E was found to be associated with a
higher sensitivity towards activated NK cells. In contrast, the
expression of activating ligands, such as MIC-A/-B, ULBP1-3 and
Hsp70 on ECs appears to be of minor importance for this NK cell
mediated activity. A sub-lethal irradiation initiated a selective up-
regulation of HLA-E on macrovascular ECs which correlated with
a decreased susceptibility to NK cell mediated lysis. In line with
these findings, treating of NK cells with an agonistic antibody
directed against the activating NK cell receptor NKG2C and ECs
with an antibody inhibiting HLA-E increased the lysis of
irradiated, HLA-E expressing primary, macrovascular HUVECs.
Since the lysis of irradiated HUVECs was not significantly affected
by an antibody directed against the inhibitory receptor NKG2A,
we speculate that the activating NKG2C receptor is dominant
over the effects of the inhibitory receptor NKG2A.
Interestingly, HLA-E expression on immortalized microvascular
ECs remained unchanged following irradiation and their lysis by
activated NK cells remained unaltered. Although the physiological
relevance of these differences in the HLA-E expression on macro-
and microvasculature has yet to be elucidated, these findings
might, among others, have future clinical implications for
radiotherapy. Analyzing differences in activating and inhibiting
NK ligands on ECs might be useful for therapeutic strategies that
combine irradiation and NK cell-based therapies. Also it will be
interesting to see the outcome of direct comparisons between
normal ECs and ECs from malignant tumor samples of the same
tissue which are currently being undertaken in our laboratory.
Materials and Methods
Cells
Human umbilical vein ECs (HUVEC) [34] are the most
common source of primary macrovascular ECs used for in vitro
studies. HUVECs were prepared by digestion using 0.1%
collagenase/trypsin solution (Sigma-Aldrich Corp., St. Louis,
MO, USA) and grown to confluence. The cells were cultured in
T25 flasks at a density of 1610
6 cells per ml in ECGM medium
supplemented with 10% v/v FCS and Supplement Mix containing
100 IU/ml polymyxin B in an incubator at 37uC in a humidified
atmosphere with 5% CO2. Cells were passaged twice a week and
harvested by incubation with trypsin/EDTA for 1 min at 37uC.
Cells undergo senescence at passages 8–10.
The cell line EA.hy926 results from a fusion of HUVECs with
the epithelial lung tumor cell line A549-8 [56]. The cell line
EA.hy926 was kindly provided by Dr. Cora-Jean S. Edgell
(University of North Carolina, Chapel Hill, USA). The cells were
grown in DMEM medium supplemented with 10% v/v FCS,
2 mM glutamine, 100 mM hypoxanthine, 0.4 mM aminopterin,
16 mM thymidine and 50 mg/l gentamicin at 37uCi na
humidified atmosphere with 5% CO2.
The human microvascular endothelial cell line CDC/EU.-
HMEC-1, further referred as HMEC, was derived by transfecting
human dermal microvascular ECs using a PBR-322 plasmid
containing the coding region for the simian virus 40 A gene
product (SV40), large T antigen to immortalize them [57]. The
cell line was cultured in MCDB 131 medium (Gibco BRL,
Karlsruhe, Germany) supplemented with 15% v/v FCS, 2 mM
glutamine (Gibco BRL), 100 mM hydrocortisone (Sigma Aldrich,
Deisenhofen, Germany), 10 ng/ml Epidermal growth factor
(EGF, Becton Dickinson, Heidelberg, Germany) and 1% w/v
penicillin/streptomycin (Gibco BRL, Karlsruhe, Germany) as
antibiotics at 37uC in a humidified atmosphere with 5% CO2.
Irradiation of ECs
Macro- and microvascular primary and immortalized ECs
(HUVECs, EA.hy926 cells and HMECs) were cultured to 75%
confluence and then irradiated with a single dose of 4 Gy at a dose
rate of 1 Gy/min (Gulmay Isodose Control, Solingen, Germany).
After a recovery period of 12 h, supernatants were centrifuged to
remove the detached cells. The surviving cell fraction was used for
further analysis. The total number of the attached and detached
cells was counted.
Von Willebrand Factor Staining
For the von Willebrand (factor VIII-related antigen) staining,
cells were seeded into 8-well m-slide. After adherence, the cells
were fixed with methanol-acetone (1:1) at room temperature for
2 min and rinsed with PBS. Samples were incubated with
polyclonal rabbit antibody against human factor VIII-related
antigen (Sigma Aldrich, Deisenhofen, Germany) at 37uC for
45 min, rinsed with PBS and incubated with goat-anti-rabbit
FITC (fluorescein-isothiocyanate)-labeled secondary antibody
(Sigma Aldrich, Deisenhofen, Germany) at 37uC for another
30 min. Cells were then washed with PBS/10% v/v FCS and cell
nuclei were stained with 1 mg/ml diamidinophenylindole (DAPI,
Roche, Mannheim, Germany).
Flow Cytometry
Cells were detached from the culture flasks using trypsin/EDTA
(Gibco BRL, Karlsruhe, Germany) at 37uC for 1 min. After two
washings in ice-cold PBS/FCS (1% v/v) cells were incubated for
30 min at 4uC with the following fluorescence-conjugated
monoclonal antibodies (mAbs): anti-CD31 (Becton Dickinson,
Heidelberg, Germany), anti-ULBP1-3, anti-MICA/B (BAMO1,
IgG1; BAMO2, IgG2a, Bamomab, Munich, Germany), anti-
HLA-E (MEM-06, Biozol, Eching, Germany), anti-MHC class I
(W6/32, Sigma, Missouri, USA), anti-Hsp70 (cmHsp70.1, multi-
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Designs, Ann Arbor, MI, USA), anti-CD54 (Dianova, Hamburg,
Germany). After another two washing steps viable, propidium
iodide-negative cells were gated and analyzed on a FACSCalibur
flow cytometer (Becton Dickinson, Heidelberg, Germany).
51Cr Release and Granzyme B ELISPOT Assays and
Inhibition/Activation studies
Briefly, viable ECs were labeled with 0.1 mCi of Na2
51CrO4
(Hartmann Analytic GmbH, Braunschweig, Germany) at 37uC for
2 h. After two washes with RPMI 1640 medium,
51Cr-labeled
target cells (1610
4) were transferred into triplicate wells of a 96-well
plate. Human NK cells which were isolated using a standard CD3/
CD19 depletion protocol (Miltenyi, Dreieich, Germany), followed
by an adherence selection of CD14
+ cells. Un-stimulated NK cells
or NK cells stimulated with TKD (2 mg/ml) and IL-2 (100 IU/ml)
were then added to the ECs at various effector to target (E:T) cell
ratios. After a 4 h co-incubation, supernatants (100 ml) were
harvested and their radioactivity determined was using a gamma
counter (Coulter). Specific lysis was calculated using the formula: %
specific lysis = (experimental release – spontaneous release)/
(maximum release –spontaneous release) 6100. The spontaneous
release for each target cell ranged between 10 and 15%.
For the granzyme B ELISPOT assay, 96-well ELISPOT plates
(Millipore GmbH, Schwalbach, Germany) were coated with
capture antibody by an overnight incubation at 4uC, after which
they were blocked using 10% v/v FCS. The effector and target
cells (3610
3) were added at different E:T ratios as indicated. After
4 h incubation at 37uC and 2 washing steps, a biotinylated
detecting antibody (2 mg/ml) was added. After additional 2
washes, the presence of granzyme B was visualized using 3-
amino-9-ethyl-carbazole substrate solution (25 min). Spots were
counted and data were analyzed using an Immuno Spot Series 3A
Analyzer (CTL-Europe GmbH, Aalen, Germany).
For inhibition/activation studies effector (TKD/IL-2-activated
NK cells) or target (HUVECs) cells were pre-incubated with
unlabeled NKG2A, NKG2C (MAB1059, MAB1381, 5 mg/ml
each, R&D systems, Minneapolis, MN, USA) or HLA-E (MEM-
06, Biozol, Eching, Germany, 5 mg/ml) antibodies for 30 min at
room temperature and then used in the granzyme B ELISPOT
assay at an E:T ratio of 1:1.
Statistical Analysis
Means between two groups were tested for differences using the
t-test or the non-parametric Mann Whitney rank sum test, means
of more than two groups were compared using the Analysis of
variance (ANOVA).
IBIDI Movie
Due to the better availability of EC lines compared to primary
ECs, HMECs were used as target cells for the videos. Killing of
HMECs by resting and TKD/IL-2-activated human NK cells at
an effector to target (E:T) ratio of 5:1. Briefly, 5,000 HMEC were
seeded into m Dishes
35 mm, low with Culture Insert (IBIDI,
Martinsried; Germany) in a volume of 70 ml RPMI-1640 medium
supplemented with 10% v/v FCS and cultured overnight. The
supernatant was removed and 25,000 NK cells (resting or IL-2
activated for 4 days) were added in a volume of 70 ml fresh
medium. Killing of target cells was filmed for 6 h. Time interval,
20 s; number of slides, 1200; totally elapsed 6 h, magnification,
106, MV; format, mpg.
Supporting Information
Video S1 Movie illustrating the attack of HMECs by
resting NK cells. Resting NK cells co-cultured with HMECs at
an E:T ratio of 10:1 for 6 h at a magnification of 10x.
(MP4)
Video S2 Movie illustrating the attack of HMECs by
TKD/IL-2-activated NK cells. TKD/IL-2-activated NK cells
co-cultured with HMECs at an E:T ratio of 10:1 for 6 h at a
magnification of 10x.
(MP4)
Video S3 Movie illustrating the attack of HMECs by
TKD/IL-2-activated NK cells. TKD/IL-2-activated NK cells
co-cultured with HMECs at an E:T ratio of 10:1 for 6 h at a
magnification of 20x.
(MP4)
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